“…Additional to its effect on neuronal cells, BNN27 induces TrkA phosphorylation of TrkA-expressing BV2 mouse glial cells in culture, decreasing the levels of interleukin (IL) 6 mRNA (Pediaditakis, Efstathopoulos, et al, 2016). BNN27 has shown beneficial and neuroprotective effects in animal models of amyotrophic lateral sclerosis (Glajch et al, 2016), retinal detachment (Tsoka et al, 2018), ketamineinduced psychosis (Zoupa et al, 2019), scopolamine-induced cognitive deficits (Pitsikas & Gravanis, 2017), and a model of retina degeneration in the streptozotocin-induced diabetic rats (Ibán-Arias et al, 2018), while recent studies also showed that this microneurotrophin is able to affect locomotion, progesterone, and testosterone levels, as well as the glutamatergic and GABAergic systems of the hippocampus and prefrontal cortex in a sexdependent way (Kokras et al, 2020). We have shown that BNN27, acting through the TrkA receptor, can exert a trophic action on OLs in vitro and in vivo in the cuprizone model of demyelination (Bonetto, et al 2017).…”